Mastercard (MA) Receives a Buy from Bernstein
Bernstein analyst Harshita Rawat maintained a Buy rating on Mastercard on October 10 and set a price target of $607.00. The company’s shares closed last Friday at $557.48.Elevate Your Investing Strategy:...
Compass Point Reaffirms Their Hold Rating on Mastercard (MA)
Compass Point analyst Dominick Gabriele maintained a Hold rating on Mastercard today and set a price target of $611.00. The company’s shares closed yesterday at $564.55.Elevate Your Investing Strategy:...
SpyBiotech Appoints Seasoned Biotech Executive Mark Leuchtenberger as Chief Executive Officer
SpyBiotech, a British biotechnology company with a novel vaccine platform technology that can target infectious diseases, cancer, and chronic diseases, has appointed Mark Leuchtenberger as its Chief Executive...